Precision Therapeutics granted European patent for its medical fluid disposal
Precision Therapeutics is pleased to announce that on July 11, 2018 the European Patent Office granted European Patent No. 2948200 covering the company's STREAMWAY System for automated, direct-to-drain medical fluid disposal, which is sold through the company's Skyline Medical division. The company is seeking national validation of its European patent in 11 European countries, including Belgium, France, Germany, Ireland, Italy, the Netherlands, Norway, Poland, Spain, Sweden and the United Kingdom. As a result of the granting of the European patent, the company has confidence that its intellectual property is protected as it executes on its sales strategy for its revolutionary, CE-marked, STREAMWAY System in Europe.